INDIA –Sanofi India (SIL) announced that Rodolfo Hrosz has been appointed as the Company’s new Managing Director, effective June 1, 2022, subject to regulatory approvals.
He will move from his current position as Sanofi’s General Manager, Consumer Healthcare business in Brazil to his new role in India as soon as the necessary regulatory approvals are obtained.
He will take over from Rajaram Narayanan, who resigned from the post with effect from April 10, after an eight-year tenure.
Rodolpho joined Sanofi in 2017 as General Supervisor of the Shopper Healthcare enterprise in Brazil and has successfully led the group through a number of transformative levels, starting from the enterprise unit’s inception to it becoming a high development contributor and a digital-acceleration reference level throughout the Sanofi Group.
Rodolfo brings a wealth of experience from business, advertising and marketing, and general management roles in a number of multinational corporations.
Prior to joining Sanofi, he worked for Pfizer, LVMH, Heineken, and Procter & Gamble in the United States and Brazil.
Aditya Narayan Chairman of the Board, Sanofi India Limited said, “We are delighted to have Rodolfo Hrosz join Sanofi India as its Managing Director and look forward to his leading the team in the further development of the Company.
“His wide experience and diverse skills make him eminently suitable for this role and we wish him all the very best for every success in his new assignment.”
Companies are increasingly appreciating the value added by variety and inclusion. With Rodolfo at the helm as Sanofi India’s new Managing Director, the Firm is poised to mobilize energies, improve agility, and face the industry’s brand-new challenges.
His extensive global experience, particularly in key emerging markets, is a valuable asset that can significantly benefit the Firm’s growth.
Other recent appointments making headlines in the Pharmaceutical industry include Pfizer and Moderna, which appointed David Denton and Jorge Gomez respectively as chief financial officers as they both seek to deploy some of the cash generated during the Covid-19 pandemic.
Pfizer, announced that David Denton will take over as CFO on May 2. Mr. Denton has been the finance chief of Lowe’s Cos., a home-improvement retailer, since 2018.
Jorge Gomez’s appointment takes effect from May 9, 2022.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
